Jesse Shefferman - 10 Jan 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Jesse Shefferman
Issuer symbol
TARA
Transactions as of
10 Jan 2022
Net transactions value
-$31,852
Form type
4
Filing time
12 Jan 2022, 16:18:49 UTC
Previous filing
05 Jan 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $31,852 -5,080 -0.58% $6.27 872,425 10 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020.